ReportsnReports | Tykerb (Head and Neck Cancer) – Analysis and Forecasts to 2020
GlobalData’s pharmaceuticals report, “Tykerb(Head and Neck Cancer )-Analysis and Forecasts to 2020” provides Zelapar sales forecast the forecast period (2014-2020). The report also includes information onHead and Neck Cancer market. This report is built using data and information sourced from GlobalData’s proprietary databases, primary and secondary research using Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData’s team of industry experts.
Note: This is a on-demand report and will be delivered within 7 business days (excluding weekends) of the purchase.
Scope
- Therapy area profile including patient population for the US, EU5 and Japan (seven major markets)
- Analysis and review of Tykerb including historical sales data
- Qualitative and quantitative assessment of market space
- Analysis of the trends, drivers and restraints shaping and defining the markets
- In-depth analysis of Tykerb including efficacy, safety, pricing, competition and other details which influence its sales potential
- Detailed sales forecast for 2014-2020 forTykerb in the US & UK
- Qualitative and quantitative assessment of market space
- Analysis of the trends, drivers and restraints shaping and defining the markets
- In-depth analysis of Tykerb including efficacy, safety, pricing, competition and other details which influence its sales potential
- Detailed sales forecast for 2014-2020 forTykerb in the US & UK
Reasons to buy
- Understand and capitalize by identifying products that are most likely to ensure a robust return
- Stay ahead of competition by understanding the changing competitive landscape
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth analysis of the drug’s performance
- Examine the historical sales performance of a drug in seven major markets
- Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth analysis of the drug’s performance
- Examine the historical sales performance of a drug in seven major markets
- Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets
Table of contents
1.1 List of Tables 2
1.2 List of Figures 3
2 Introduction 4
2.1 Head and Neck Cancer Market 4
2.2 Epidemiology 4
2.3 Etiology 9
2.4 GlobalData Analysis and Forecasts Report Guidance 10
3 Head and Neck Cancer Disease: Market Characterization 11
3.1 Head and Neck Cancer Disease Market 11
3.2 Head and Neck Cancer Disease Market Forecasts and CAGR 11
3.3 Drivers for the Head and Neck Cancer Disease Market 12
3.3.1 High Incidence 12
3.3.2 Low Initial Diagnosis Rate 13
3.3.3 Emergence of Targeted Therapies and Vaccines 13
4 Tumor–Node–Metastases (TNM) Classification of Head and Neck Cancer 14
5 Tykerb 22
5.1 Introduction 22
5.2 Mechanism of Action 22
5.3 Clinical Studies 22
5.4 Approval History of Tykerb 23
5.5 Factors Affecting Sales of Tykerb 23
5.5.1 Head and Neck Cancer Market 23
5.5.2 High Efficacy 23
5.5.3 Oral Dosing 23
5.5.4 Superiority of Targeted Therapy 24
5.6 Drug Risk Benefit Score 24
5.6.1 Efficacy 24
5.6.2 Safety 24
5.6.3 Compliance 24
5.6.4 Dosing Convenience 25
5.7 Intensity of Competition 25
5.8 Sales forecast 25
5.8.1 Target patient Pool of Tykerb 25
5.8.2 Dosing 26
5.8.3 Market Penetration 26
5.8.4 Annual Cost of Therapy 26
5.8.5 Sales Projections of Tykerb 27
6 Head and Neck Cancer Market: Appendix 36
6.1 Market Definitions 36
6.2 List of Abberiviations 36
6.3 Research Methodology 36
6.3.1 Coverage 37
6.3.2 Secondary Research 37
6.3.3 Forecasting 37
6.3.4 Number of Patients Approved to take the Drug 38
6.3.5 Net Penetration of Drug 38
6.3.6 Net Annual Dosing 39
6.3.7 Annual Cost of Therapy 39
6.3.8 Primary Research 39
6.3.9 Expert Panels 40
6.4 Contact Us 40
6.5 Disclaimer 40
6.6 Sources 40
1.1 List of Tables 2
1.2 List of Figures 3
2 Introduction 4
2.1 Head and Neck Cancer Market 4
2.2 Epidemiology 4
2.3 Etiology 9
2.4 GlobalData Analysis and Forecasts Report Guidance 10
3 Head and Neck Cancer Disease: Market Characterization 11
3.1 Head and Neck Cancer Disease Market 11
3.2 Head and Neck Cancer Disease Market Forecasts and CAGR 11
3.3 Drivers for the Head and Neck Cancer Disease Market 12
3.3.1 High Incidence 12
3.3.2 Low Initial Diagnosis Rate 13
3.3.3 Emergence of Targeted Therapies and Vaccines 13
4 Tumor–Node–Metastases (TNM) Classification of Head and Neck Cancer 14
5 Tykerb 22
5.1 Introduction 22
5.2 Mechanism of Action 22
5.3 Clinical Studies 22
5.4 Approval History of Tykerb 23
5.5 Factors Affecting Sales of Tykerb 23
5.5.1 Head and Neck Cancer Market 23
5.5.2 High Efficacy 23
5.5.3 Oral Dosing 23
5.5.4 Superiority of Targeted Therapy 24
5.6 Drug Risk Benefit Score 24
5.6.1 Efficacy 24
5.6.2 Safety 24
5.6.3 Compliance 24
5.6.4 Dosing Convenience 25
5.7 Intensity of Competition 25
5.8 Sales forecast 25
5.8.1 Target patient Pool of Tykerb 25
5.8.2 Dosing 26
5.8.3 Market Penetration 26
5.8.4 Annual Cost of Therapy 26
5.8.5 Sales Projections of Tykerb 27
6 Head and Neck Cancer Market: Appendix 36
6.1 Market Definitions 36
6.2 List of Abberiviations 36
6.3 Research Methodology 36
6.3.1 Coverage 37
6.3.2 Secondary Research 37
6.3.3 Forecasting 37
6.3.4 Number of Patients Approved to take the Drug 38
6.3.5 Net Penetration of Drug 38
6.3.6 Net Annual Dosing 39
6.3.7 Annual Cost of Therapy 39
6.3.8 Primary Research 39
6.3.9 Expert Panels 40
6.4 Contact Us 40
6.5 Disclaimer 40
6.6 Sources 40
Latest Market Research Reports:
About Us:
ReportsnReports.com is an online market research library of 135,000+ reports and in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers. Visit http://www.reportsnreports.com/ for more details.
Contact:
Priyank Tiwari
7557 Rambler road,
Suite 727, Dallas, TX 75231
Tel: +1-888-391-5441
sales@reportsandreports.com
Visit our Market Research Blog @ http://www.reportsnreportsblog.com/
Connect with us on:
Twitter @ http://www.twitter.com/marketsreports
No comments:
Post a Comment